| Q37252918 | A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV |
| Q41252059 | HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains |
| Q89955514 | Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis |
| Q33843560 | Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity. |
| Q33784784 | Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes. |
| Q36684660 | Pulmonary collectins modulate strain-specific influenza a virus infection and host responses |
| Q34046062 | Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs |
| Q40226257 | Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection |
| Q57185064 | Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins |
| Q43627168 | Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus |
| Q36827336 | The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus. |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |